Abstract B126: Co-clinical Trial of Novel Bispecific Anti-Her2 Antibody Zanidatamab in Patient-Derived Xenografts
Molecular cancer therapeutics(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined